{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:29:50Z","timestamp":1791300590639,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mutation Research\/Genetic Toxicology and Environmental Mutagenesis"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.mrgentox.2011.02.005","type":"journal-article","created":{"date-parts":[[2011,2,19]],"date-time":"2011-02-19T10:05:13Z","timestamp":1298109913000},"page":"206-210","source":"Crossref","is-referenced-by-count":27,"title":["DNA damage in leukocytes from pretreatment mucopolysaccharidosis type II patients; protective effect of enzyme replacement therapy"],"prefix":"10.1016","volume":"721","author":[{"given":"Let\u00edcia","family":"Filippon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.Y.","family":"Wayhs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana M.","family":"Atik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanusa","family":"Manfredini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvani","family":"Herber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarissa G.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida V.D.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Giugliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen R.","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mrgentox.2011.02.005_bib0005","first-page":"104","article-title":"A rare disease in two brothers","volume":"10","author":"Hunter","year":"1917","journal-title":"Proc. R. Soc. Med."},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0010","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3421","article-title":"The mucopolysaccharidoses","author":"Neufeld","year":"2001"},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0015","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/ajmg.a.20314","article-title":"Incidence of the mucopolysaccharidoses in Western Australia","volume":"123","author":"Nelson","year":"2003","journal-title":"Am. J. Med. Genet. Part A"},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0020","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s10545-005-0112-z","article-title":"Cumulative incidence rates of the mucopolysaccharidoses in Germany","volume":"28","author":"Baehner","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0025","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10545-010-9093-7","article-title":"The birth prevalence of lysosomal storage disorders in the Czech Republic: comparison with data in different populations","volume":"33","author":"Poup\u011btov\u00e1","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0030","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0035","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/sj.ejhg.5201044","article-title":"Prevalence of lysosomal storage diseases in Portugal","volume":"12","author":"Pinto","year":"2004","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0040","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/ajmg.a.32320","article-title":"Mucopolysaccharidoses in Brazil: what happens from birth to biochemical diagnosis?","volume":"146","author":"Vieira","year":"2008","journal-title":"Am. J. Med. Genet. Part A"},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0045","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/s004310050685","article-title":"Selective screening of 10,000 high-risk Brazilian patients for the detection of inborn errors of metabolism","volume":"156","author":"Coelho","year":"1997","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0050","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1542\/peds.2007-1350","article-title":"Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome)","volume":"121","author":"Martin","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0055","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.pediatrneurol.2004.10.009","article-title":"Mucopolysaccharidosis type II in females: case report and review of literature","volume":"32","author":"Tuschl","year":"2005","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0060","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1023\/A:1005525931994","article-title":"Long-term follow-up following bone marrow transplantation for Hunter disease","volume":"22","author":"Vellodi","year":"1999","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0065","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00431-007-0635-4","article-title":"Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy","volume":"167","author":"Wraith","year":"2008","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0070","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ymgme.2006.09.001","article-title":"A phase I\/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome)","volume":"90","author":"Muenzer","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0075","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.gim.0000232477.37660.fb","article-title":"A phase II\/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)","volume":"8","author":"Muenzer","year":"2006","journal-title":"Genet. Med."},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0080","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ymgme.2009.08.006","article-title":"Japan Elaprase\u00ae treatment (JET) study: idursulfase enzyme replacement therapy in adult patients with attenuated Hunter syndrome (mucopolysaccharidosis II, MPS II)","volume":"99","author":"Okuyama","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0085","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3233\/PRM-2010-0112","article-title":"Musculoskeletal health in Hunter disease (MPS II): ERT improves functional outcomes","volume":"3","author":"White","year":"2010","journal-title":"J. Pediatr. Rehabil. Med."},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0090","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ijdevneu.2009.01.001","article-title":"Effect of short- and long-term exposition to high phenylalanine blood levels on oxidative damage in phenylketonuric patients","volume":"27","author":"Sitta","year":"2009","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0095","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11011-006-9030-5","article-title":"Evidence that oxidative stress is increased in plasma from patients with maple syrup urine disease","volume":"21","author":"Barschak","year":"2006","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0100","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.mrgentox.2010.07.008","article-title":"Prevention by l-carnitine of DNA damage induced by propionic and l-methylmalonic acids in human peripheral leukocytes in vitro","volume":"702","author":"Ribas","year":"2010","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0105","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s10571-008-9335-5","article-title":"Alterations in oxidative markers in the cerebellum and peripheral organs in MPS I mice","volume":"29","author":"Reolon","year":"2009","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0110","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cca.2007.09.008","article-title":"Mutational and oxidative stress analysis in patients with mucopolysaccharidosis type I undergoing enzyme replacement therapy","volume":"387","author":"Pereira","year":"2007","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0115","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2353\/ajpath.2008.070564","article-title":"Molecular pathogenesis of genetic and inherited diseases mechanism of glycosaminoglycan-mediated bone and joint disease: implications for the mucopolysaccharidoses and other connective tissue diseases","volume":"172","author":"Simonaro","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0120","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cyto.2005.03.006","article-title":"TNF-alpha levels and TNF-alpha gene polymorphism in type I Gaucher disease","volume":"31","author":"Altarescu","year":"2005","journal-title":"Cytokine"},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0125","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10545-007-0716-6","article-title":"Correlation between interleukin-6 promoter and C-reactive protein (CRP) polymorphisms and CRP levels with the Mainz severity score index for Fabry disease","volume":"31","author":"Altarescu","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0130","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/brain\/awg089","article-title":"Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis","volume":"126","author":"Jeyakumar","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0135","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/ana.20242","article-title":"NSAIDs increase survival in the Sandhoff disease mouse: synergy with N-butyldeoxynojirimycin","volume":"56","author":"Jeyakumar","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0140","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/jnr.21134","article-title":"Cytokines, neurotrophins, and oxidative stress in brain disease from mucopolysaccharidosis IIIB","volume":"85","author":"Villani","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0145","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1073\/pnas.252784899","article-title":"Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB","volume":"100","author":"Ohmi","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0150","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.brainres.2009.03.071","article-title":"Mucopolysaccharidosis IIIB: oxidative damage and cytotoxic cell involvement in the neuronal pathogenesis","volume":"1279","author":"Villani","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0155","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/clinchem\/38.6.803","article-title":"Measuring urinary glycosaminoglycans in the presence of protein: an improved screening procedure for mucopolysaccharidoses based on dimethylmethylene blue","volume":"38","author":"de Jong","year":"1992","journal-title":"Clin. Chem."},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0160","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1023\/A:1012763026526","article-title":"A fluorimetric enzyme assay for the diagnosis of MPS II (Hunter disease)","volume":"24","author":"Voznyi","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0165","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0076-6879(90)86134-H","article-title":"Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal","volume":"186","author":"Esterbauer","year":"1990","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0170","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/0076-6879(90)86141-H","article-title":"Determination of carbonyl content in oxidatively modified proteins","volume":"186","author":"Levine","year":"1990","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0175","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0014-4827(88)90265-0","article-title":"A simple technique for quantification of low levels of DNA damage in individuals cells","volume":"175","author":"Singh","year":"1988","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0180","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J","article-title":"Single cell gel\/comet assay: guidelines for in vitro and in vivo genetic toxicology testing","volume":"35","author":"Tice","year":"2000","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0185","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/mutage\/18.1.45","article-title":"Recommendations for conducting the in vivo alkaline comet assay","volume":"18","author":"Hartmann","year":"2003","journal-title":"Mutagenesis"},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0190","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1177\/002215540104900912","article-title":"A silver staining method for single-cell gel assay","volume":"49","author":"Nadin","year":"2001","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0195","series-title":"Free Radicals in Biology and Medicine","first-page":"246","article-title":"Oxidative stress: adaptation, damage, repair and death","author":"Halliwell","year":"1999"},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0200","series-title":"Free Radicals in Biology and Medicine","author":"Halliwell","year":"2007"},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0205","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1152\/physrev.00018.2001","article-title":"Free radicals in the physiological control of cell function","volume":"82","author":"Dr\u00f6ge","year":"2002","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0210","series-title":"Free Radicals: From Basic Science to Medicine","first-page":"425","article-title":"Free radicals and antioxidants in muscular neurological diseases and disorders","author":"Reznick","year":"1993"},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0215","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10571-008-9313-y","article-title":"l-Carnitine blood levels and oxidative stress in treated phenylketonuric patients","volume":"29","author":"Sitta","year":"2009","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0220","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ijdevneu.2007.08.008","article-title":"Induction of lipid peroxidation and decrease of antioxidant defenses in symptomatic and asymptomatic patients with X-linked adrenoleukodystrophy","volume":"25","author":"Deon","year":"2007","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0225","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1023\/B:BOLI.0000037353.13085.e2","article-title":"The role of oxidative damage in the neuropathology of organic acidurias: insights from animal studies","volume":"27","author":"Wajner","year":"2004","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0230","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11011-007-9077-y","article-title":"Oxidative stress in plasma from maple syrup urine disease patients during treatment","volume":"23","author":"Barschak","year":"2008","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0235","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0006-8993(02)03573-4","article-title":"3-Hydroxyglutaric acid induces oxidative stress and decreases the antioxidant defences in cerebral cortex of young rats","volume":"956","author":"Latini","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0240","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/15216540600904885","article-title":"Lysosomal labilization","volume":"58","author":"Terman","year":"2006","journal-title":"IUBMB Life"},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0245","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1196\/annals.1297.048","article-title":"Lysosomal redox-active iron is important for oxidative stress-induced DNA damage","volume":"1019","author":"Kurz","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0250","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mrrev.2007.10.003","article-title":"Mechanism of oxidative DNA damage repair and relevance to human pathology","volume":"659","author":"D\u2019Errico","year":"2008","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0255","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ymeth.2009.02.016","article-title":"The comet assay: a sensitive method for detecting DNA damage in individual cells","volume":"48","author":"Liao","year":"2009","journal-title":"Methods"},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0260","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1373\/clinchem.2005.061408","article-title":"Biomarkers of oxidative damage in human disease","volume":"52","author":"Dalle-Donne","year":"2006","journal-title":"Clin. Chem."},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0265","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2165\/00002512-200118090-00004","article-title":"Role of free radicals in the neurodegenerative diseases","volume":"18","author":"Halliwell","year":"2001","journal-title":"Drugs Aging"},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0270","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cca.2005.09.009","article-title":"Does measurement of oxidative damage to DNA have clinical significance?","volume":"365","author":"Cooke","year":"2006","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0275","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1089\/ars.2007.1830","article-title":"DNA damage and repair: from molecular mechanisms to health implications","volume":"10","author":"Altieri","year":"2008","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0280","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/mutage\/10.6.555","article-title":"The contribution of excision repair to the DNA effects seen in the alkaline single cell gel test (comet assay)","volume":"10","author":"Speit","year":"1995","journal-title":"Mutagenesis"},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0285","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.mrgentox.2009.07.013","article-title":"Evidence that DNA damage is associated to phenylalanine blood levels in leukocytes from phenylketonuric patients","volume":"679","author":"Sitta","year":"2009","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0290","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neuint.2008.08.011","article-title":"Chronic hyperhomocysteinemia alters antioxidant defenses and increases DNA damage in brain and blood of rats: protective effect of folic acid","volume":"54","author":"Matt\u00e9","year":"2009","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.mrgentox.2011.02.005_bib0295","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00401-007-0325-3","article-title":"Mechanisms of neurodegeneration in mucopolysaccharidoses II and IIIB: analysis of human brain tissue","volume":"115","author":"Hamano","year":"2008","journal-title":"Acta Neuropathol."}],"container-title":["Mutation Research\/Genetic Toxicology and Environmental Mutagenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383571811000611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383571811000611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T18:41:59Z","timestamp":1592332919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1383571811000611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S1383571811000611"],"URL":"https:\/\/doi.org\/10.1016\/j.mrgentox.2011.02.005","relation":{},"ISSN":["1383-5718"],"issn-type":[{"value":"1383-5718","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}